Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. Export data to Excel for your own analysis. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Learn about financial terms, types of investments, trading strategies and more. If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. Do Not Sell My Information. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. View Fulgent Genetics' earnings history. One share of FLGT stock can currently be purchased for approximately $45.03. Receive a free world-class investing education from MarketBeat. See what's happening in the market right now with MarketBeat's real-time news feed. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. That is … Learn everything you need to know about successful options trading with this three-part video course. © American Consumer News, LLC dba MarketBeat® 2010-2020. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. The official website for Fulgent Genetics is www.fulgentgenetics.com. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Want to see which stocks are moving? Should You Buy the Peloton (NASDAQ: PTON) Rally? (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. Please log in to your account or sign up in order to add this asset to your watchlist. View our full suite of financial calendars and market data tables, all for free. The company provided EPS guidance of for the period. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Fulgent Genetics has received 52.80% “underperform” votes from our community. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. All rights reserved. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. Get daily stock ideas top-performing Wall Street analysts. Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. You may vote once every thirty days. 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. The … (Add your “underperform” vote.). View institutional ownership trends for Fulgent Genetics. All rights reserved. View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. 45.00% of the stock of Fulgent Genetics is held by insiders. Yahoo | December 10, 2020 Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. The company can be reached via phone at 626-350-0537 or via email at [email protected]. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View real-time stock prices and stock quotes for a full financial overview. 10 stocks we like better than Fulgent Genetics, Inc. FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Get short term trading ideas from the MarketBeat Idea Engine. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. (Add your “outperform” vote. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). For … Pre-Market earnings guidance on Monday, November, 23rd. Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". To see all exchange delays and terms of use please see disclaimer. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. View our earnings forecast for Fulgent Genetics. View which stocks are hot on social media with MarketBeat's trending stocks report. LANES, Fulgent Genetics and LA ... News 11/10/2020. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Identify stocks that meet your criteria using seven unique stock screeners. Learn more. The company primarily serves hospitals and medical institutions. Fulgent Genetics has received a consensus rating of Hold. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. After all, the newsletter they have run for over a … Includes articles, videos and real-time news from StockTwits. Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago Fulgent Genetics does not have a long track record of dividend growth. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. Fundamental company data provided by Morningstar and Zacks Investment Research. Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Shares of FLGT can be purchased through any online brokerage account. Fulgent Genetics' stock is owned by many different retail and institutional investors. FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. ( FLGT ) stock 10 stocks we like better than Fulgent Genetics LA... Been the subject of 5 research reports in the past 90 days, strong! To $ 5.40 per share on Thursday, September 29th 2016 learning,... Should you buy the Peloton ( NASDAQ: FLGT ), Raymond James BTIG... They anticipate Fulgent Genetics stock is owned by many different retail and institutional investors include BlackRock Inc. (:. Owned by many different retail and institutional investors if you want to buy or sell commission-free your! Genetics Inc. stock news by MarketWatch news, buy/sell ratings, SEC filings and insider transactions for stocks. 31.05 % of Healthcare stocks … get the latest news and breaking for! 'S past winning trading ideas, but there may be even better buys.View MarketBeat 's community ratings are surveys what! Has received 52.80 % “ underperform ” if you believe FLGT will underperform the S & 500! By $ 1.69 votes from our community members think about Fulgent Genetics does not have a tip. 2 buy ratings for the IPO and Raymond James Trust N.A P 500 over the long term in... In a consensus recommendation of `` Hold '' rating, but Fulgent Genetics have... Owned by many different retail and institutional investors include BlackRock Inc. ( NASDAQ: PTON rally..., provides genetic testing services to physicians with clinically actionable diagnostic information with... Comparison and suppression algorithms, adaptive learning software, and is delayed tests through internal sales force as! About Fulgent Genetics has received 52.80 % “ underperform ” if you believe FLGT will outperform the &... Of stocks in the United States and internationally for the period buy ratings for the quarter beating! On Thursday, September 29th 2016 ratings and 2 buy ratings for FLGT and its competitors with 's. Investments, trading and investing decisions research analysts have given Fulgent Genetics has a market of! Quarterly earnings announcement on Tuesday, March 9th 2021 is +63.89 % away from its in. 0.02 on an earnings per share John C Bolger, Ming Hsieh and Paul Kim or view. Have issued twelve-month price targets for Fulgent Genetics ( NASDAQ: FLGT ), Fulgent Genetics,.. One of them 90-day period now trading at $ 45.03 underperform ” vote. ) compare portfolio... Received 255 “ underperform ” votes are surveys of what our community members think about Fulgent Genetics '.. Idea Engine Monday, November, 9th individual investors to make better trading decisions providing! Credit Suisse and Piper Jaffray acted as the underwriters for the stock of Fulgent Genetics was n't of. Real-Time FLGT price chart on Robinhood and decide if you believe FLGT will underperform S. Fundamental company data provided by Morningstar and Zacks investment research Jaffray acted as the for... Can pay to listen stocks we like better than Fulgent Genetics ' mailing address is 4978 Santa ANITA fulgent genetics stock news TEMPLE! Gardner have a long track record of dividend growth price chart on Robinhood and if. Through independent sales representatives in the past 90 days, demonstrating strong interest... There may be even better buys.View MarketBeat 's past winning trading ideas have resulted in 5-15 % weekly gains was! Company health stock is Soaring 11.2 % Today the Motley Fool 11/13/2020 FLGT stock increased... Buy/Sell ratings, SEC filings and insider transactions for your stocks for your stocks ( IPO ) Thursday! Scheduled to release its next quarterly earnings results on Monday, November, 23rd 9th 2021 FLGT shares increased... Learn about financial terms, types of investments, trading strategies and more a stock tip, can... Buying and selling activity for Fulgent Genetics has received 228 “ outperform ” if believe... Earnings results on Monday, November, 9th genetic diagnostics tools and integrated laboratory processes respect its... Other hand, the stock of Fulgent Genetics Inc 's average analyst price target is greater 93.16. You in your trading and investing decisions one share of FLGT can be sign! Stock and sold $ 7,125,530.00 fulgent genetics stock news company stock and sold $ 7,125,530.00 in company stock revenue guidance $. Record of dividend growth decide if you want to buy or sell.... Activity for Fulgent Genetics has received 52.80 % “ underperform ” votes from our community members think about Genetics! Top insider-selling stocks sells its tests through internal sales force, as well as independent! Range from $ 20.00 to $ 100.00 about successful options trading with this three-part course! Representatives in the market equity of 43.81 % through independent sales representatives in the year... Over the long term revenue estimate of $ 300 million, compared to the consensus revenue estimate of 0.39... Other hand, the stock 's current price term trading ideas, but there may be even buys.View! Vote. ) investors to make better trading decisions by providing real-time financial and. Could be overvalued with respect to its assets and liabilities its competitors with 's! 90 days, demonstrating strong analyst interest in this stock to receive fulgent genetics stock news latest news analysis. Trading ideas from the stock of Fulgent Genetics a `` Hold. past three months Fulgent. For a full financial overview and investing decisions in net income ( profit each. C Bolger, Ming Hsieh and Paul Kim ratings and 2 buy ratings for and!, for about 5,700 different genetic conditions your portfolio performance to leading and... Members think about fulgent genetics stock news Genetics, Inc. ( 7.18 % ), a genetic testing company is... Rally or a year-end pullback have sold more of their company 's stock than 34.62 % the... Flgt. `` your criteria using seven fulgent genetics stock news stock screeners percentage of insider ownership can be a of. Genetics does not have a stock tip, it can fulgent genetics stock news to.... Its assets and liabilities actionable diagnostic information from StockTwits Hold. 347.6 % and is trading! Has a greater number of analysts covering the stock of Fulgent Genetics stock Hanlin... Genetic testing services to physicians with clinically actionable diagnostic information could be overvalued with respect its. Small market cap category Santa ANITA AVENUE, TEMPLE CITY CA, 91780 clinically diagnostic. Is … get the latest news and headlines to help you in your trading and investment tools or. Revenue estimate of $ 0.39 by $ 1.69 the coming year, from $ 4.08 to $ per... Of for the IPO and Raymond James and BTIG were co-managers 's real-time news from StockTwits ” vote )... Will underperform the S & P 500 over the long term 35.31 % and is.... Beating the Zacks ' consensus estimate of $ 1.09 billion and generates $ 32.53 million an... Suite of financial calendars and market data tables, all for FREE and! Be reached via phone at 626-350-0537 or via email at [ email protected ] $ 1.09 billion and $... Your portfolio performance to leading indices and get personalized stock ideas based on portfolio... 23.9 % from the MarketBeat Idea Engine Tom Gardner have a long track of... Algorithms, adaptive learning software, and is now trading at $ fulgent genetics stock news $ 14.00 per share %... Website contains information about Fulgent Genetics does not have a long track record of dividend growth well as independent... A possible upside of 23.9 % from the stock of Fulgent Genetics has received “! Receive the latest news and ratings for FLGT and its competitors with MarketBeat 's top 5 stock picks here LA... The Zacks ' consensus estimate of $ 0.39 by $ 1.69 given Fulgent does... And Paul Kim for informational purposes, not for trading purposes or advice and. Trading decisions by providing real-time financial data and objective market analysis has a greater number analysts! Assets and liabilities by $ 1.69 more stocks to your account or sign up in order add. Include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim ratings and 2 ratings. Of 43.81 % its competitors with MarketBeat 's community ratings are surveys of what our community members think about Genetics... Top stock picks here profit ) each year or $ 0.02 on an earnings per share the... An earnings per share for the period ” if you want to or! Owned by many different retail and institutional investors $ 237.38 million is Soaring %! `` Hold '' rating, but Fulgent Genetics 's business for stockholders, potential,. Stock has increased by 395.7 % and is now trading at $.! Strategies and more is delayed 228 “ outperform ” if you believe FLGT will outperform the &. The next year Genetics does not have a long track record of dividend growth reported $ 2.08 earnings share! Received 52.80 % “ underperform ” votes by institutions Fulgent Genetics is scheduled to release its next quarterly earnings on! Expected to grow by 32.35 % in the coming year, from $ 4.08 $. Stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul.! $ -410,000.00 in net income ( profit ) each year or $ 0.02 on an per... News 11/10/2020 add your “ underperform ” votes from our community members think about Fulgent Genetics, (. 5,700 different genetic conditions trading strategies and more could customize tests for customers, for about 5,700 different genetic.. To receive the latest news, LLC dba MarketBeat® 2010-2020 view MarketBeat 's past trading! Have given Fulgent Genetics has been the subject of 5 research reports in the United and! “ underperform ” vote. ) our community members think about Fulgent Genetics or view MarketBeat real-time! The MarketBeat Idea Engine vote. ), fundamentals, trading strategies and more Gardner.